Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00814073
Title A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap
Acronym AB06006
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors AB Science
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA


No variant requirements are available.